These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 483235)

  • 21. The effect of platelet function inhibitors on experimental venous thrombosis formation in rabbits.
    Arfors KE; Bergqvist D; Tangen O
    Acta Chir Scand; 1975; 141(1):40-2. PubMed ID: 1092111
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dipyridamole potentiates the inhibition of platelet aggregation by aspirin (in human platelet rich plasma and whole blood).
    Violi F; Praticò D; Iuliano L; Balsano F
    J Lipid Mediat; 1991; 4(1):61-7. PubMed ID: 1909906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibition of blood platelet function].
    Glusa E
    Z Gesamte Inn Med; 1979 Jan; 34(1):17-22. PubMed ID: 34940
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of anti-aggregating substances.
    Vermylen J
    Acta Clin Belg; 1975; 30(3):204-9. PubMed ID: 1231459
    [No Abstract]   [Full Text] [Related]  

  • 25. Modulation of the inhibitory action of prostaglandin E1 on platelet aggregation in rats: a study with ticlopidine, aspirin, dipyridamole and sulfinpyrazone.
    Tuong CC; Ferrand C; Aubert D; Loubrie JC; Tuong A
    Biochem Pharmacol; 1982 Mar; 31(6):1147-50. PubMed ID: 7200772
    [No Abstract]   [Full Text] [Related]  

  • 26. Proceedings: Comparison of in vivo and in vitro effects of platelet function suppressing drugs.
    Buchanan M; Hirsh J
    Thromb Diath Haemorrh; 1975 Nov; 34(2):552. PubMed ID: 1198423
    [No Abstract]   [Full Text] [Related]  

  • 27. The influence of calcium antagonists on endothelium.
    Hladovec J
    Arzneimittelforschung; 1979; 29(8):1101-3. PubMed ID: 583006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiplatelet therapy.
    Turpie AG
    Clin Haematol; 1981 Jun; 10(2):497-520. PubMed ID: 7032786
    [No Abstract]   [Full Text] [Related]  

  • 30. Antithrombotic therapy for vascular prosthesis: an experimental model testing platelet inhibitory drugs.
    McCollum CN; Crow MJ; Rajah SM; Kester RC
    Surgery; 1980 Jun; 87(6):668-76. PubMed ID: 6445604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The influence of antiplatelet drugs on injury-stimulated migration of cultured smooth muscle cells.
    Grunwald J; Haudenschild CC
    Artery; 1985; 12(5):324-36. PubMed ID: 4051753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiplatelet agents: rationale and results.
    Kelton JG
    Clin Haematol; 1983 Feb; 12(1):311-54. PubMed ID: 6132693
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effects of heparin, sulfinpyrazone and acetylsalicylic acid on the collagen-induced thromboyte aggregation].
    Haas S; Fritsche HM; Ketterl R; Leimgruber D; Blümel G
    Med Welt; 1979 Jun; 30(22):862-7. PubMed ID: 440074
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of etofylline clofibrate on experimental thrombosis and platelet function.
    Sim AK; Davies ME; McCraw AP; Metz G
    Arzneimittelforschung; 1980; 30(11b):2042-5. PubMed ID: 7194057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The effect of low-dose acetylsalicylic acid on platelet aggregation parameters in vitro].
    Cardona M; Escolar G; Roig E; Bastida E; Ordinas A; Sanz G
    Rev Esp Cardiol; 1992 Apr; 45(4):264-9. PubMed ID: 1598464
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Acetylsalicylic acid, blood platelets and the vessel wall].
    Huijens PC; van den Berg CA; Imandt LM; Langenhuijsen MM
    Ned Tijdschr Geneeskd; 1981 Jun; 125(23):921-3. PubMed ID: 7266688
    [No Abstract]   [Full Text] [Related]  

  • 37. [Prevention of thrombosis by thrombocyte inhibitors. 1. Cell regulation mechanisms and pharmacological modification].
    Hansen MS; Birgens HS
    Ugeskr Laeger; 1980 Jan; 142(5):303-5. PubMed ID: 6243811
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of aspirin and dipyridamole on the degradation of adenosine diphosphate by cultured cells derived from bovine pulmonary artery.
    Crutchley DJ; Ryan US; Ryan JW
    J Clin Invest; 1980 Jul; 66(1):29-35. PubMed ID: 7400307
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mode of action of currently used antiplatelet drugs.
    de Gaetano G; Bertele' V; Cerletti C
    Agents Actions Suppl; 1986; 20():191-201. PubMed ID: 3101442
    [No Abstract]   [Full Text] [Related]  

  • 40. [Relationship between inhibitory effect of anti-platelet drugs on platelet aggregation and clinical value (author's transl)].
    Yasunaga K; Kanzaki M
    Nihon Ketsueki Gakkai Zasshi; 1979 Jun; 42(3):552-3. PubMed ID: 495017
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.